» Articles » PMID: 21766415

Drug Carriers for Vascular Drug Delivery

Overview
Journal IUBMB Life
Date 2011 Jul 19
PMID 21766415
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The currently used drug carriers for vascular drug delivery are reviewed. The human vascular system possesses unique physiological features that can be exploited for enhanced and effective targeted drug delivery. Although the thin layer of endothelial cells (EC) lines the interior surface of blood vessels forming an interface between circulating blood in the lumen and the tissue beyond the vessel wall, it can also function as a target for drugs to EC in different vascular areas. ECs overexpress specific cell-surface molecules under various pathological conditions (tumor neovasculature, inflammation, oxidative stress, and thrombosis), which are absent or barely detectable in established normal blood vessels. By coupling unique endothelial surface markers, such as antibodies, specific peptides, and growth factors to a variety of drug carriers, effective active vascular-targeted drug delivery systems can be achieved. This review focuses on the recent advances and strategies for effective targeted vascular drug delivery using a variety of drug-loaded carriers along with new targeting approaches that can be used in the design and optimization of such carriers.

Citing Articles

Scalable lipid droplet microarray fabrication, validation, and screening.

Bell T, Kusi-Appiah A, Tocci V, Lyu P, Zhu L, Zhu F PLoS One. 2024; 19(7):e0304736.

PMID: 38968248 PMC: 11226032. DOI: 10.1371/journal.pone.0304736.


Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications.

Ding J, Ding X, Liao W, Lu Z Mater Today Bio. 2024; 24:100913.

PMID: 38188647 PMC: 10767221. DOI: 10.1016/j.mtbio.2023.100913.


Dual Coating of Chitosan and Albumin Negates the Protein Corona-Induced Reduced Vascular Adhesion of Targeted PLGA Microparticles in Human Blood.

Lopez-Cazares G, Eniola-Adefeso O Pharmaceutics. 2022; 14(5).

PMID: 35631604 PMC: 9143524. DOI: 10.3390/pharmaceutics14051018.


Low Dose Curcumin Administered in Hyaluronic Acid-Based Nanocapsules Induces Hypotensive Effect in Hypertensive Rats.

Czyzynska-Cichon I, Janik-Hazuka M, Szafraniec-Szczesny J, Jasinski K, Weglarz W, Zapotoczny S Int J Nanomedicine. 2021; 16:1377-1390.

PMID: 33658778 PMC: 7917338. DOI: 10.2147/IJN.S291945.


Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases.

Pala R, Anju V, Dyavaiah M, Busi S, Nauli S Int J Nanomedicine. 2020; 15:3741-3769.

PMID: 32547026 PMC: 7266400. DOI: 10.2147/IJN.S250872.